Treatment outcomes in patients with relapsed Graves' disease. [PDF]
Carlini JA +4 more
europepmc +1 more source
Case Report: Graves' disease in a toddler with maple syrup urine disease: therapeutic challenges and surgical resolution. [PDF]
Ghandora H +5 more
europepmc +1 more source
Response to methimazole in Graves' disease. The European Multicenter Study Group.
OBJECTIVE: A variety of regimens continue to be used in the treatment of Graves' disease with antithyroid drugs. We have investigated the factors which determine the initial response to methimazole (time until euthyroidism is achieved) in Graves ...
Tegler L +6 more
core
Drug-induced liver injury due to potassium iodide during thyroid storm. [PDF]
Takano N +3 more
europepmc +1 more source
Dual Antithyroid Drug-Induced Agranulocytosis in Graves' Disease With Decompensated Heart Failure: A Multidisciplinary Approach. [PDF]
Voci A, Seraj L, Shehu M, Haxhiu A.
europepmc +1 more source
FAK inhibition following acute olfactory epithelial inflammation promotes neurogenesis and functional recovery through stem cell CNTF. [PDF]
Cox D +6 more
europepmc +1 more source
Biochemical, Immunohistochemical and Behavioral Effects of Spexin in a Methimazole-Induced Hypothyroidism Rat Model. [PDF]
Koçak S +4 more
europepmc +1 more source
HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. [PDF]
Kasamatsu D +4 more
europepmc +1 more source
Infection-Associated Transient Neutropenia Mimicking Methimazole-Induced Agranulocytosis in Graves' Disease: A Diagnostic Dilemma. [PDF]
Saiprasad S +3 more
europepmc +1 more source

